What type of study is this?

This is a Pre-Registered Trial study.

What question did this study set out to answer?

To assess the effects of imetelstat on clonal burden and RBC transfusion independence in lower-risk myelodysplastic neoplasms.

January 14, 2026LeukemiaOpen Access

Modulation of the clonal burden in patients with lower-risk myelodysplastic neoplasms treated with imetelstat

View Full Paper

Ask AI

Bookmark

Authors

VSV. SantiniUniversity of Florence AZAmer M. ZeidanYale Cancer Center KEKoen Van EygenAZ Groeninge

Discussion

Member takes

Implication

Exploratory analysis shows imetelstat improves erythropoiesis in patients with lower-risk myelodysplastic neoplasms, indicating potential disease modification.

Key Points

To assess the effects of imetelstat on clonal burden and RBC transfusion independence in lower-risk myelodysplastic neoplasms.
Phase 3 exploratory analysis of the IMerge study
Patients with non-del(5q), RBC transfusion-dependent LR-MDS
Comparison of imetelstat-treated patients to placebo recipients
Higher rates of RBC transfusion independence were observed with imetelstat treatment
Imetelstat led to greater reductions in variant allele frequency of mutations compared to placebo
Marked decrease in telomerase activity was associated with longer RBC transfusion independence

Cite This Study

Santini et al. (2026) studied this question.

synapsesocial.com/papers/6966f32713bf7a6f02c00f69 https://doi.org/10.1038/s41375-025-02831-z

View Full Paper

Ask AI

Bookmark

Implication

Exploratory analysis shows imetelstat improves erythropoiesis in patients with lower-risk myelodysplastic neoplasms, indicating potential disease modification.